BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹75 Cr | ₹5,999,757 Cr | ₹0.00 Cr | ₹43 Cr | ₹25 Cr |
What is the latest Operating Profit of BETA DRUGS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹75 Cr |
| Mar2025 | ₹5,999,757 Cr |
| Mar2024 | ₹0.00 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹25 Cr |
How is Operating Profit of BETA DRUGS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹75 Cr | -100.00 | |
| Mar2025 | ₹5,999,757 Cr | 599,975,652,400.00 | |
| Mar2024 | ₹0.00 Cr | -100.00 | |
| Mar2023 | ₹43 Cr | 72.57 | |
| Mar2022 | ₹25 Cr | - | |
Compare Operating Profit of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,103.0 Cr | 6.3% | -10% | 12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 6.3% |
-10% |
12.8% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses